drug
BEAM-304
Preclinicalupdated 3mo agoby $BEAM Beam Therapeutics Inc.
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Bespoke gene-editing outfit abandons lead program, cuts ‘several’ employeesSeven months after launching with $16 million in seed financing, Jennifer Doudna’s Aurora Therapeutics is pivoting away from its lead indication, phenylketonuria, owing to growing competition in th…biospace · 6d ago
Data sources
last refreshed 32m ago
Found something off?
comments(0)
5-min edit window · permanent after that